• Search
  • Advanced Search
Korean J Med > Volume 93(3); 2018 > Article
2018 대한부정맥학회 비판막성 심방세동 환자의 뇌졸중 예방 지침
Erratum

Korean J Med 2018;93(3):311-312.

DOI: https://doi.org/10.3904/kjm.2018.93.2.87.e1

2018 대한부정맥학회 비판막성 심방세동 환자의 뇌졸중 예방 지침

이정명1, 정보영2, 차명진3, 이지현4, 임우현5, 김태훈2, 신승용6, 엄재선2, 임홍의7, 김진배1, 김준수8

1경희대학교병원 순환기내과

2연세대학교 세브란스병원 순환기내과

3서울대학교병원 순환기내과

4서울대학교 분당병원 순환기내과

5서울대학교 보라매병원 순환기내과

6중앙대학교병원 순환기내과

7고려대학교 구로병원 순환기내과

8성균관대학교 삼성서울병원 순환기내과

2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation

Jung Myung Lee1, Boyoung Joung2, Myung-Jin Cha3, Ji Hyun Lee4, Woo Hyun Lim5, Tae-Hoon Kim2, Seung Yong Shin6, Jae-Sun Uhm2, Hong Euy Lim7, Jin-Bae Kim1, Jun Soo Kim8

1Division of Cardiology, Kyung Hee University Hospital, Seoul, Korea

2Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea

3Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea

4Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea

5Division of Cardiology, Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea

6Department of Cardiology, Chung-Ang University Hospital, Seoul, Korea

7Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea

8Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Published online 2018. 6. 1

Copyright © 2018 The Korean Association of Internal Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Korean J Med 2018;93:87-109. https://doi.org/10.3904/kjm.2018.93.2.87
다음과 같이 본문 내 Table 5에 오류가 있어 수정합니다.

Table 5.
Guidance for temporary interruption of NOAC before surgery
Dabigatran
 Apixaban, edoxaban, rivaroxaban
 Low-risk surgery High-risk surgery
Low-risk surgery High-risk surgery
Creatinine clearance >80 mL/min 24 hours 48 hours 24 hours 48 hours
Creatinine clearance 50-80 mL/min 36 hours 72 hours 24 hours 48 hours
Creatinine clearance 30-50 mL/min 48 hours 96 hours 24 hours 48 hours
Creatinine clearance 15-30 mL/min Not indicated Not indicated 36 hours 48 hours

NOAC, non-vitamin K antagonist oral anticoagulant.

Table 5.
Guidance for temporary interruption of NOAC before surgery
Dabigatran
 Apixaban, edoxaban, rivaroxaban
Low risk surgery High risk surgery Low risk surgery High risk surgery
Creatinine clearance >80 mL/min 24 hours 48 hours 24 hours 48 hours
Creatinine clearance 50-80 mL/min 36 hours 72 hours 24 hours 48 hours
Creatinine clearance 30-50 mL/min 48 hours 96 hours 24 hours 48 hours
Creatinine clearance 15-30 mL/min Not indicated Not indicated 36 hours 48 hours

NOAC, non-vitamin K antagonist oral anticoagulant.

TOOLS
METRICS Graph View
  • 1 Crossref
  •  0 Scopus
  • 5,102 View
  • 571 Download
Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next